Announced Mon, 26 Oct, 2026 · 13:17 IST

Board to approve September 2026 quarterly and half-year results

Results View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹77.05

prior close

₹77.71

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.9% vs market

Pharmaceuticals peers, median of 174sector+1.2%-1.7% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.3

15m

+0.3

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5+0.4-0.9+1.2-1.7

Next day

+3.8+2.1+1.7+3.1+0.7

+3.3+2.2+1.1+4.8-1.5

+3.7pendingpending+4.7-1.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on October 30, 2026 to approve unaudited results for the quarter and half-year ended September 30, 2026. The subject line mentions August, but the meeting date in the body is October 30. Insider trading is closed from October 1 through November 1 for designated persons and their relatives.

Likely market impact

The results may influence near-term share prices. Insider trading remains restricted until 48 hours after the results are declared.